Stocksigma LogoStocksigma Logo

Torrent Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 4,979 (+50.8% YoY | +1.2% QoQ) ■ EBITDA: 1,666 (+53.8% YoY | +0.1% QoQ) ■ EBITDA Margin (%): 33.5 (+66 bps YoY | -35 bps QoQ) ■ PAT: 534 (-9.6%

Torrent Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Torrent Pharmaceuticals Ltd · Financial Result · 23 Oct 2026, 10:00 pm

Torrent Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 4,979 (+50.8% YoY | +1.2% QoQ) ■ EBITDA: 1,666 (+53.8% YoY | +0.1% QoQ) ■ EBITDA Margin (%): 33.5 (+66 bps YoY | -35 bps QoQ) ■ PAT: 534 (-9.6% YoY | -5.7% QoQ) ■ EPS (INR): 14.1 (-19.5% YoY | -5.5% QoQ)

Original exchange filing (PDF)

More announcements from Torrent Pharmaceuticals Ltd

All Torrent Pharmaceuticals Ltd announcements